Skip to main content
. 2020 Oct 5;11:163. doi: 10.4103/ijpvm.IJPVM_45_19

Table 1.

Baseline characteristics of study participants according to hemoconcentration status

Total (N=390) Negative HC (N=38) Positive HC (N=31) P
Age (years) 70.5±11.9 71.0±12.1 72.1±10.5 0.70*
Gender (male) 261 (66.9) 26 (68.4) 24 (77.4) 0.40**
BMI (kg/m2) 26.7±4.8 25.0±3.8 28.6±4.5 0.01*
SBP (mmHg) 132.8±28.2 125.1±22.5 131.7±27.1 0.27*
DBP (mmHg) 82.2±16.5 78.4±13.3 80.1±15.0 0.61*
Hb (g/dl) 13.2±4.2 13.0±2.2 10.6±2.2 <0.001*
BUN (mg/dl) 27.6±17.1 39.6±28.6 37.3±27.2 0.76*
Cr (mg/dl) 1.6±1.2 1.8±1.3 2.3±1.9 0.23*
Follow-up duration (days) 245.8±122.5 219.0±130.2 272.6±110.6 0.13*
Positive ischemic heart disease 318 (82.4) 29 (78.4) 20 (66.7) 0.28**
Positive COPD 40 (10.3) 5 (13.2) 6 (19.4) 0.48**
Positive renal diseases 96 (24.8) 9 (23.7) 11 (35.5) 0.28**
Positive hypertension 254 (65.6) 27 (71.1) 19 (61.3) 0.39**
Positive diabetes mellitus 184 (47.2) 21 (55.3) 17 (54.8) 0.97**
Positive myocardial infarction 126 (32.6) 8 (21.1) 8 (25.8) 0.64**
Readmission 65 (16.7) 3 (9.7) 6 (15.8) 0.45**
Death 62 (15.9) 27 (71.1) 24 (77.4) 0.54**

*P values are obtained from Independent T-test. **P values are obtained from Chi-square Test. BMI=Body mass index, SBP=Systolic blood pressure, DBP=Diastolic blood pressure, Hb=Hemoglobin, BUN=Blood urea nitrogen, Cr=Creatinine, COPD=Chronic obstructive pulmonary diseases